Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice

Circulation. Cardiovascular Imaging
Caroline JungHarald Ittrich

Abstract

The aim of this study was to assess whether high-density lipoprotein (HDL) labeled with superparamagnetic iron oxide nanoparticles (SPIOs) and quantum dots was able to detect atherosclerotic lesions in mice after intravenous and intraperitoneal injection by multimodal imaging. Nanoparticle-labeled HDLs (NP-HDLs) were characterized in vitro by dynamic light scattering and size exclusion chromatography with subsequent cholesterol and fluorescence measurements. For biodistribution and blood clearance studies, NP-HDL(SPIOs) radiolabeled with (59)Fe (NP-HDL(59Fe-SPIOs)) were injected intravenously or intraperitoneally into ApoE knockout mice (n=6), and radioactivity was measured using a gamma counter. NP-HDL accumulation within atherosclerotic plaques in vivo and ex vivo was estimated by MRI at 7 Tesla, ex vivo confocal fluorescence microscopy, x-ray fluorescence microscopy, and histological analysis (n=3). Statistical analyses were performed using a 2-tailed Student t-test. In vitro characterization of NP-HDL confirmed properties similar to endogenous HDL. Blood concentration time curves showed a biexponential decrease for the intravenous injection, whereas a slow increase followed by a steady state was noted for intraperitoneal in...Continue Reading

References

Jan 1, 1977·Physics in Medicine and Biology·J S BraunsfurthH C Heinrich
Jan 23, 1992·The New England Journal of Medicine·V FusterJ H Chesebro
Sep 23, 2000·Nature·A J Lusis
May 15, 2002·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·A ShaishD Harats
Oct 8, 2004·Journal of the American Chemical Society·Dmitri V TalapinHorst Weller
Dec 17, 2004·Journal of the American Chemical Society·Juan C FriasZahi A Fayad
Mar 2, 2005·Nature Reviews. Drug Discovery·Patrick Linsel-Nitschke, Alan R Tall
Mar 14, 2008·Current Drug Targets·Jonathan E FeigEdward A Fisher
Jun 4, 2008·Current Opinion in Cardiology·Matilda FlorentinDimitri P Mikhailidis
Oct 23, 2008·Nano Letters·David P CormodeWillem J M Mulder
Apr 8, 2011·Current Pharmaceutical Biotechnology·Joerg Heeren, Oliver Bruns
Oct 22, 2011·Nature Reviews. Drug Discovery·Mark E LobattoWillem J M Mulder

❮ Previous
Next ❯

Citations

Jul 2, 2015·Biochemical and Biophysical Research Communications·Maya JuenetDidier Letourneur
Oct 31, 2016·Advanced Drug Delivery Reviews·C Shad ThaxtonDavid P Cormode
Feb 11, 2016·Chemical Society Reviews·Neus FeliuWolfgang J Parak
Jun 29, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Roxana Cristina PopescuDiana Savu
Aug 7, 2018·British Journal of Pharmacology·Joseph Pierre AboumsallemBart De Geest
Aug 19, 2014·Toxicological Sciences : an Official Journal of the Society of Toxicology·Akmal A El-GhorHanan Ramadan H Mohamed
Nov 10, 2017·Nature Biomedical Engineering·Oliver T BrunsMoungi G Bawendi
Jul 1, 2016·Chemical Science·Lyndsay M RandolphNathan C Gianneschi
Jan 28, 2020·Nano Convergence·Jun ChenHo-Wook Jun
Jun 21, 2020·Chemistry and Physics of Lipids·Liliana Aranda-LaraKeila Isaac-Olivé
Sep 25, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Dennis Pedersbæk, Jens B Simonsen
Aug 15, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·John C Stendahl, Albert J Sinusas
Aug 22, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·John C Stendahl, Albert J Sinusas
Jul 25, 2021·International Journal of Environmental Research and Public Health·Elizabeth FiremanMordechai Reuven Kramer

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.